What PT. Pharos Indonesia does

PT. Pharos Indonesia is a major Indonesian pharmaceutical manufacturer founded on September 30, 1971 by Drs. Eddie Lembong and Andre Lembong, headquartered in South Jakarta. The company produces and markets over 400 products spanning prescription drugs (ethical pharmaceuticals), OTC medicines, nutritional supplements, skincare/medical devices, and traditional herbal medicines. Its portfolio includes recognized brands such as Microlax (laxatives), Proris (fever medicine), Polysilane (antacids), Thermolyte Plus, Nourish Skin, Omepros (omega supplements), and Praxion (children's paracetamol). The company employs proprietary drug delivery technologies including spray dryer solid dispersion and particle micronization for enhanced bioavailability, and was the first Indonesian pharmaceutical company to obtain CPOB (Good Manufacturing Practice) certification in 1990, supplemented by ISO 9001:2015 quality management certification.

The business operates across five wholly-owned entities under the Pharos Group umbrella, including PT. Pharos Indonesia, PT. Prima Medika Laboratories, PT. Primaxcel Inovasi, PT. Perusahaan Dagang dan Industri Faratu, and PT. Perintis Pelayanan Parappa, plus the Century Healthcare and Apotek Generik retail pharmacy chains totaling 400+ pharmacy locations. Revenue is generated through unit-pricing across all products sold via owned retail pharmacies, third-party pharmacy chains (Kimia Farma, Watsons, Century), independent pharmacies, and e-commerce marketplaces (Tokopedia, Shopee), targeting general consumers, parents with children, and adults/elderly across Indonesia. The go-to-market combines mass-market distribution, healthcare professional engagement (e.g., INSPIRE Roadshow with Ikatan Apoteker Indonesia), community health programs, and regulatory partnerships with BPOM (Indonesia's food and drug authority).

The company is privately held, led by President Commissioner Dr. Andre Lembong (son of the founder), with 1,001-5,000 employees. It has accumulated multiple Top Brand Awards in Indonesia (2022) across fever medicine, laxative, vitamin E, and slimming medicine categories, and maintains an R&D division established in 1972 that has developed 500+ products. Current strategic focus includes product line extensions (e.g., MicrolaxTab tablet launch in June 2025), category diversification into skincare/medical devices, and e-commerce channel expansion.

Name

PT. Pharos Indonesia

Legal name

PT. Pharos Indonesia

Website

https://pharos.co.id

Company type

Private

Founded year

1971

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

PT. Pharos Indonesia is a major Indonesian pharmaceutical manufacturer founded in 1971, producing 400+ prescription drugs, OTC medicines, supplements, and skincare products. It serves Indonesian consumers through 400+ owned retail pharmacies, third-party chains, and e-commerce marketplaces.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (32541), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmacies and Drug Retailers (45611)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834), Retail-Drug Stores And Proprietary Stores (5912)

akta.pro primary industry

Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO)

Keywords

• Pharmaceutical manufacturing
• Over-the-counter medicines
• Prescription drugs
• Nutritional supplements
• Medical devices

Headquarters

HQ city

South Jakarta, DKI Jakarta

HQ country

Indonesia

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Marketing or Sales, Personnel, Operations, Infrastructure

Revenue model

1. Prescription Drugs (Ethical Pharmaceuticals): Manufacture and marketing of ethical/prescription drugs including antibiotics, analgesics, and specialty medications distributed through pharmacies with medical professional recommendations.
2. Over-the-Counter (OTC) Products: Non-prescription pharmaceutical products including fever medicine (Proris), laxatives (Microlax), antacids (Polysilane), allergy medicine (Ozen), cough remedies (Rexcof), and topical preparations sold directly to consumers through pharmacies and retail stores.
3. Nutritional Supplements: Health supplements including omega formulations (Omepros), fucoidan-based products (Colidan), fish oil (Fishqua, Omepros), children's multivitamins (Igastrum), and specialized supplements for cholesterol management and digestive health.
4. Skincare and Beauty Products: Skincare line including Nourish Beauty Care acne patches, Illuminare sun protection, and dermatological products distributed through pharmacies, retail, and e-commerce channels.
5. Traditional/Herbal Medicines: Herbal and traditional medicine products as part of the diversified product portfolio under the Pharos Group umbrella.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

PT. Pharos Indonesia manufactures, markets, and distributes a diversified pharmaceutical portfolio of more than 400 products spanning ethical/prescription drugs, over-the-counter (OTC) medicines, nutritional supplements, herbal/traditional medicines, skincare/beauty products, and medical devices. The company sells through pharmacy chains (including its own Century Healthcare and Apotek Generik retail network of 400+ outlets), third-party retailers, and e-commerce marketplaces to Indonesian consumers.

Product overview

PT. Pharos Indonesia is one of Indonesia's largest pharmaceutical companies producing and marketing innovative pharmaceutical and healthcare products. The company offers a diversified portfolio of hundreds of products across multiple categories including prescription drugs (obat resep), OTC/non-prescription medicines (obat non-resep/OTC), supplements (suplemen), herbal products, food products, skincare/beauty products, and medical devices (alat kesehatan). Key brands include Microlax (laxative), Proris (fever medicine), Polysilane (antacid), Nourish Beauty Care Acne Plast (skincare), Omepros (omega supplements), Colidan (digestive health), Praxion (children's fever medicine), and various topical medicines. The company also operates retail pharmacy chains including Century Healthcare and Apotek Generik with over 400 pharmacies across Indonesia.

Differentiator

Problem solved

Functional benefit

Brands

• Thermolyte Plus: Slimming medicine product - Top Brand Award 2022 winner in Slimming Medicine category
• Microlax
• Proris
• Nourish Skin
• Polysilane
• Illuminare
• Nourish Beauty Care
• HospiNet
• Panakea

Products and services

• Thermolyte Plus Slimming medicine category product targeted at adult consumers managing body weight.
• Microlax Laxative medication for treating constipation, available as 5ml enema gel and as MicrolaxTab chewable tablets; suitable for adults, elderly, children, pregnant women, and bedridden patients.
• Proris Ibuprofen-based antipyretic fever medicine available in suspension and caplet forms for children.
• Nourish Skin Vitamin E skincare supplement product for adult consumers.
• Polysilane Antacid suspension and tablets for treating excess stomach acid, gastritis, gastric ulcers, and duodenal ulcers; includes Polysilane Junior variant for children.
• Polysilane Max Chronic gastric medication containing Famotidine and antacids for persistent gastric symptoms.
• Nourish Beauty Care Acne Plast Acne patch medical device skincare line using Korean-formulated hydrocolloid technology, with variants targeted at acne care, brightening, and sun protection.
• Keloplast Silicone gel medical sheet for flattening and reducing keloid and scar tissue, available in 5x6cm and 6x10cm sizes.
• Cofitklin Instant hand sanitizer spray with non-rinse, non-sticky formula containing Benzalkonium Chloride 0.05% and Ethanol 25%.
• Septico Antiseptic spray containing Octenidine 0.1% for preventing and treating wound infections, transparent with no staining.
• Igastrum Children's multivitamin suspension containing Colostrum bovine, DHA, calcium, L-Lysine, and multiple vitamins for immune support and bone/teeth growth.
• Colidan Fucoidan-based seaweed extract supplement for maintaining stomach health, available in 50mg and 100mg capsule variants.
• Vermoran Anthelmintic chewable tablet containing Mebendazole 500mg for treatment of common worm infections.
• STOP-X Cream Topical analgesic cream for relieving muscle aches, joint pain, sprains, and headaches.
• Omepros Omega 3, 6, 9 supplement with GLA from Black Currant Seed Oil, Salmon Oil, Flaxseed Oil, and Olive Oil for supporting cardiovascular health.
• FishQua Squalene supplement extracted from Dogfish Shark liver oil with Vitamin E, halal certified for general health maintenance.
• Ozen Prescription allergy medication containing Cetirizine HCl 10mg for perennial rhinitis, allergic rhinitis, and chronic idiopathic urticaria.
• Praxion Paracetamol children's suspension using particle micronization technology for faster absorption and improved taste, for fever reduction and pain relief.
• Exedra Rema Combined Ibuprofen 200mg and Paracetamol 400mg caplet for moderate joint pain, menstrual pain, and post-operative pain.
• Alfabio Aromatherapy balm containing Clove, Black Cumin, and Lemongrass for muscle/joint pain, bruises, sprains, and nasal congestion.
• Cloveril Antifungal ointment containing Salicylic acid and Sulfur for treating ringworm, scabies, athlete's foot, and itching.
• Altadis Antifungal cream containing Miconazole nitrate 2% for skin infections including Pityriasis versicolor, Tinea corporis, Tinea cruris, and Tinea pedis.
• Rodemol Paracetamol 500mg tablet/caplet for headache, toothache, and fever reduction.
• Rodemol Extra Paracetamol 500mg with Caffeine 50mg caplet for headache and toothache relief.
• Rexcof Plus Cough expectorant syrup containing Bromhexine HCl and Guaifenesin for productive cough treatment.
• Oparin Topical gel containing Heparin Sodium 200 IU for treating surface phlebitis, excessive venous blockage, sports injuries, and accident injuries.

Quantifiable outcome

• Over 500 products developed through R&D since 1972
• +2 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Nine partnerships are on record, tiered minor and core.

• Senior Club IndonesiaminorStrategic or Co-development Partner · 1 March 2026Community wellness partnership for elderly health education, supporting Senior Club Indonesia activities in commemoration of National Music Day.
• Universitas BPD SemarangminorStrategic or Co-development Partner · 1 February 2026Educational partnership hosting Glow Up Tanpa Tekanan talkshow on healthy lifestyle for young generation with hundreds of students from SMA/SMK/MA schools.
• Ikatan Apoteker Indonesia (IAI)coreStrategic or Co-development Partner · 1 December 2024Partnership for INSPIRE Roadshow (Indonesian Smart Pharmacy and Entrepreneurship) - professional pharmacy education seminars conducted on December 21-22, 2024 in Bogor and Bekasi for pharmacist competency development.
• Kimia FarmacoreChannel Partner/ Reseller/ DistributorMajor retail pharmacy chain distribution partnership for Pharos pharmaceutical and OTC products across Indonesia.
• WatsonscoreChannel Partner/ Reseller/ DistributorHealth and beauty retail chain distributing Pharos products including supplements, OTC medicines, and skincare products.
• CenturycoreChannel Partner/ Reseller/ DistributorPharmacy chain distribution partnership for Pharos pharmaceutical products.
• BPOM RIcoreOthersParticipation in BPOM initiatives including Safe Sound Fest 2026, SIGAP OM BPOM RI launch support, and Expo BPOM 2026 for 25th anniversary. Supports BPOM's Net-Zero Carbon Programme through mangrove ecosystem conservation.
• TokopediacoreChannel Partner/ Reseller/ DistributorE-commerce marketplace distribution partnership making Pharos products available to consumers through Tokopedia online platform.
• ShopeecoreChannel Partner/ Reseller/ DistributorE-commerce marketplace distribution partnership making Pharos products available to consumers through Shopee online platform.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• PT Kimia Farma (Persero) Tbk: State-owned Indonesian pharma manufacturer and one of the largest retail pharmacy chains in Indonesia. Comparable to Pharos as both a manufacturer and a channel partner/retail pharmacy operator.
• Tempo Scan Pacific: Listed Indonesian pharma with prescription, OTC, and consumer health brands (e.g., Bodrex, Neo Rheumacyl). Closely comparable to Pharos in OTC category leadership and Indonesian distribution.
• Kalbe Farma: Indonesia's largest pharmaceutical company, offering prescription drugs, OTC, supplements, and nutrition products with national distribution. Most direct comp to Pharos across branded pharma, OTC, and consumer health.
• Dexa Medica: Major Indonesian pharmaceutical group with branded prescription, OTC, and supplement products distributed nationally. Comparable to Pharos in therapeutic breadth and Indonesia-only focus.
• Sanbe Farma: Indonesian pharmaceutical manufacturer producing prescription, OTC, and supplement products. Comparable mid-to-large domestic pharma peer with similar ethical and OTC portfolio mix.
• Darya-Varia Laboratoria: Indonesian pharmaceutical company producing prescription and consumer health products, including supplements and OTC lines. Comparable mid-cap domestic pharma peer.
• Indofarma (PT Indofarma Sukses Makmur): Indonesian state-affiliated pharma manufacturer producing branded generics, OTC, and herbal products. Comparable to Pharos in domestic manufacturing focus and JKN-linked distribution.

Broad incumbents

• Bayer Indonesia: Multinational pharma with established OTC brands in Indonesia (e.g., analgesics, vitamins). Overlaps with Pharos in OTC and supplement categories through a wider global portfolio.
• PT Merck Tbk (Merck Indonesia): Subsidiary of global Merck operating in Indonesia across pharma, life science, and consumer health. Comparable to Pharos in prescription/OTC breadth but as part of a multinational portfolio.
• PT Unilever Indonesia (Consumer Health): Multinational FMCG/consumer health player in Indonesia with OTC-adjacent products (pain, vitamins, personal care). Comparable to Pharos in mass-market Indonesian consumer health distribution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/pharos-indonesia

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PT. Pharos Indonesia